Published in Viral Immunol on April 04, 2014
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2011) 7.79
Intussusception among infants given an oral rotavirus vaccine. N Engl J Med (2001) 5.33
Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol (2004) 5.20
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion. EMBO J (2001) 2.43
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38
Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol (2009) 2.21
Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12
Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis (2013) 1.84
Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol (2010) 1.57
Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine (2011) 1.51
Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest (2002) 1.34
Genotype constellation and evolution of group A rotaviruses infecting humans. Curr Opin Virol (2012) 1.29
Structural polymorphism of the major capsid protein of rotavirus. EMBO J (2001) 1.29
Structure of rotavirus. Curr Top Microbiol Immunol (1994) 1.12
Investigation of porcine circovirus contamination in human vaccines. Biologicals (2012) 1.12
Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem (2011) 1.01
Rotavirus vaccines: update on global impact and future priorities. Hum Vaccin (2011) 0.92
The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response. Arch Virol (2000) 0.91
Amino acid domains 280-297 of VP6 and 531-554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection. Arch Virol (2007) 0.90
Full genomic analysis of human rotavirus strain TB-Chen isolated in China. Virology (2008) 0.89
Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4. J Virol (2008) 0.88
Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine (2012) 0.87
Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins. Mol Immunol (1991) 0.87
Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus. Biochem J (2003) 0.85
Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother (2013) 0.84
Epitope mapping of the major inner capsid protein of group A rotavirus using peptide synthesis. Virology (1993) 0.84
Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals (2002) 0.82
Rotavirus subunit vaccines. Arch Virol Suppl (1996) 0.82
Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev Vaccines (2013) 0.81
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Mol Immunol (2005) 0.81
Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles. Vaccine (1992) 0.79
Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes. Virol J (2009) 0.78
Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine. Int J Biol Macromol (2013) 0.77
Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Nephrol Dial Transplant (2009) 1.58
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One (2012) 1.30
Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol (2013) 1.20
Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem (2011) 1.01
Full genomic analysis of human rotavirus strain TB-Chen isolated in China. Virology (2008) 0.89
Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome. Nephrology (Carlton) (2009) 0.87
Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. Am J Nephrol (2013) 0.81
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Mol Immunol (2005) 0.81
Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis. Contrib Nephrol (2013) 0.81
Treatment and prognosis of primary focal segmental glomerulosclerosis. Contrib Nephrol (2013) 0.80
Application of RIFLE criteria in patients with multiple myeloma with acute kidney injury: a 15-year retrospective, single center, cohort study. Leuk Lymphoma (2013) 0.79
Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial. Contrib Nephrol (2013) 0.79
Two brothers in one Chinese family with collagen type III glomerulopathy. Am J Kidney Dis (2007) 0.78
ACTN4 gene mutations and single nucleotide polymorphisms in idiopathic focal segmental glomerulosclerosis. Nephron Clin Pract (2009) 0.78
Field-flow fractionation of magnetic particles in a cyclic magnetic field. J Chromatogr A (2011) 0.77
Twenty-one novel mutations identified in the COL4A5 gene in Chinese patients with X-linked Alport's syndrome confirmed by skin biopsy. Nephrol Dial Transplant (2011) 0.77
Malignant hypertension complicated by acute renal failure. BMJ Case Rep (2009) 0.75
Transthyretin-related hereditary amyloidosis with recurrent vomiting and renal insufficiency as the initial presentation: A case report. Medicine (Baltimore) (2017) 0.75
Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus. Virol J (2014) 0.75
[A comparative study of pathological voice based on traditional acoustic characteristics and nonlinear features]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2014) 0.75
Re-evaluation of the classification system for membranoproliferative glomerulonephritis. Contrib Nephrol (2013) 0.75
The importance of sensitive screening for abnormal glucose metabolism in patients with IgA nephropathy. Clin Nephrol (2016) 0.75